BioCentury | Apr 15, 2013
Company News

Microcide, Pfizer deal

...bacterial genes essential for bacterial viability to use as targets for new classes of antibiotics. Microcide Pharmaceuticals Inc....
BioCentury | Oct 31, 2005
Finance

Ebb & Flow

...about 10,000 women. IDEV hopes to submit an NDA for PRO 2000, which contains a microcide...
BioCentury | Dec 24, 2001
Product Development

Infectious metrics

..."it should scale up to man." ETRX was formed by the merger this year between Microcide Pharmaceuticals Inc....
...said. A similar story can be told of Microcide. When it was founded in 1994, Microcide...
...led to the delivery of several efflux pump inhibitors for use treating Pseudomonas infections to Microcide...
BioCentury | Dec 3, 2001
Company News

Genteric management update

...VP of finance and administration, formerly CFO and VP of finance and corporate development at Microcide Pharmaceuticals Inc. WIR...
BioCentury | Nov 12, 2001
Finance

Sleep and dreams

...of Essential Therapeutics (ETRX), which was formed last month by the merger of Althexis and Microcide...
BioCentury | Oct 29, 2001
Company News

Althexis Co. Inc., Microcide deal

...and will trade on NASDAQ under the symbol ETRX. Althexis Co. Inc. , Waltham, Mass. Microcide Pharmaceuticals Inc....
BioCentury | Oct 25, 2001
Financial News

MCDE, Althexis complete merger, raise money

Microcide (MCDE) and Althexis completed their previously announced merger, and raised $57 million from Prospect Venture Partners; New Enterprise Associates; and Schroder Ventures. The combined company was renamed Essential Therapeutics, and is expected to begin...
BioCentury | Oct 8, 2001
Company News

Microcide, J&J deal

...of orally-active cephalosporin to treat resistant bacterial strains common to nosocomial and community acquired infections. Microcide Pharmaceuticals Inc....
BioCentury | Sep 24, 2001
Tools & Techniques

Virtual ICAAC

...Cubist Pharmaceuticals Inc. 's Daptomycin; anti-hepatitis B compounds from Bayer AG ; and reports by Microcide Pharmaceuticals Inc....
...action that could be complementary to treatment with IFN-alpha and/or lamivudine. Microcide pumps it out Microcide...
BioCentury | Sep 4, 2001
Strategy

Back to School 2001: Integration

...functional activity of proteins, and structure-based drug design. It recently announced plans to merge with Microcide Pharmaceuticals Inc....
Items per page:
1 - 10 of 69
BioCentury | Apr 15, 2013
Company News

Microcide, Pfizer deal

...bacterial genes essential for bacterial viability to use as targets for new classes of antibiotics. Microcide Pharmaceuticals Inc....
BioCentury | Oct 31, 2005
Finance

Ebb & Flow

...about 10,000 women. IDEV hopes to submit an NDA for PRO 2000, which contains a microcide...
BioCentury | Dec 24, 2001
Product Development

Infectious metrics

..."it should scale up to man." ETRX was formed by the merger this year between Microcide Pharmaceuticals Inc....
...said. A similar story can be told of Microcide. When it was founded in 1994, Microcide...
...led to the delivery of several efflux pump inhibitors for use treating Pseudomonas infections to Microcide...
BioCentury | Dec 3, 2001
Company News

Genteric management update

...VP of finance and administration, formerly CFO and VP of finance and corporate development at Microcide Pharmaceuticals Inc. WIR...
BioCentury | Nov 12, 2001
Finance

Sleep and dreams

...of Essential Therapeutics (ETRX), which was formed last month by the merger of Althexis and Microcide...
BioCentury | Oct 29, 2001
Company News

Althexis Co. Inc., Microcide deal

...and will trade on NASDAQ under the symbol ETRX. Althexis Co. Inc. , Waltham, Mass. Microcide Pharmaceuticals Inc....
BioCentury | Oct 25, 2001
Financial News

MCDE, Althexis complete merger, raise money

Microcide (MCDE) and Althexis completed their previously announced merger, and raised $57 million from Prospect Venture Partners; New Enterprise Associates; and Schroder Ventures. The combined company was renamed Essential Therapeutics, and is expected to begin...
BioCentury | Oct 8, 2001
Company News

Microcide, J&J deal

...of orally-active cephalosporin to treat resistant bacterial strains common to nosocomial and community acquired infections. Microcide Pharmaceuticals Inc....
BioCentury | Sep 24, 2001
Tools & Techniques

Virtual ICAAC

...Cubist Pharmaceuticals Inc. 's Daptomycin; anti-hepatitis B compounds from Bayer AG ; and reports by Microcide Pharmaceuticals Inc....
...action that could be complementary to treatment with IFN-alpha and/or lamivudine. Microcide pumps it out Microcide...
BioCentury | Sep 4, 2001
Strategy

Back to School 2001: Integration

...functional activity of proteins, and structure-based drug design. It recently announced plans to merge with Microcide Pharmaceuticals Inc....
Items per page:
1 - 10 of 69